FindTrial
Sign In

Effect of weight reduction on gastroesophageal reflux in obese subjects

Effect of weight reduction on gastroesophageal reflux in obese subjects - Reflux and Obesity

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON32499
Enrollment
50
Registered
2008-07-29
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

GERD reflux

Interventions

None listed

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Men and women > 18 years of age - BMI > 30 kg/m2

Exclusion criteria

Exclusion criteria: - Medication that affects the motility of the upper gastrointestinal tract (anti-cholinergic drugs, theophylline, calcium blocking agents, opioids) - Severe concomitant disease - Extended abdominal surgery in the past - Present motility disorders

Design outcomes

Primary

MeasureTime frame
The change in reflux symptoms and objective measurements of gastroesophageal reflux (time pH—

Secondary

MeasureTime frame
- Basal LES pressure - Incidence of TLESR's - Number of acid and non-acid ('weakly acidic') reflux episodes - Symptom Association Probability - Diary Report—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)